March 2019 // Company

Updated: Jun 11, 2019

Synendos Therapeutics was selected for Venture Leaders in Life Sciences 2019 and visits Boston in June. The programme offers a unique opportunity to meet with US investor and startup ecosystem to foster international growth.


https://www.venturelab.ch/venture-leaders-lifesciences

Recent Posts

See All

Synendos Therapeutics has been awarded with the Innosuisse Certificate Synendos has been awarded the Innosuisse certificate by Innosuisse Innovation Council. The Innosuisse certificate reflects remark

Synendos Therapeutics is ranked TOP 100 Swiss Startups 2022 We are honored to be listed for the second year in a row as one of the TOP 100 Swiss Startups 2022. A big thank you to our team, partners, c

Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board.